If we put research at the heart of epidemic response, it’s a double win – helping fight outbreaks that are underway and protecting us in the future.
Human infection studies have the power to rapidly accelerate the development of much-needed vaccines and treatments. Find out what they are, how they work and why they are important.
The global community showed the power of working together during the West African Ebola epidemic. Continuing to do so could be key to improving epidemic preparedness.
Three years on from an unprecedented epidemic in Central and South America, families affected by Zika are still benefiting from research studies supported since the outbreak began.
Lassa fever is now on the priority list of the World Health Organization and the Coalition for Epidemic Preparedness. But we need to continue to fill in the gaps in research.
Wellcome is making an initial fund of up to £2 million available to support a rapid response to the new Ebola outbreak in the Democratic Republic of Congo (DRC).
In March 2017, Wellcome announced five ambitious goals to support research globally. Today we look at what we have achieved so far and what we are working towards in 2018.
A ‘typhoid superbug’ in Pakistan has been in headlines around the world. Researchers identified a typhoid strain that has become resistant to multiple antibiotics.